We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Pushes Back All Orphan Drug Reviews by 30 Days
FDA Pushes Back All Orphan Drug Reviews by 30 Days
FDA regulators are pushing back the clock on orphan drug reviews from 90 days to 120 days in an effort to keep pace with heavier-than-expected workloads.